Built to Last, Ready to Scale
Our Mission & Vision
To create research and educational initiatives that uncover politically attractive, non-obvious solutions to today’s major economic challenges and equip change-makers to act with impact.
To become the leading nonpartisan think tank delivering a better future to all Americans.
We passed the only major capital-access legislation since 1940. We’re due for more change.
The Weild Foundation
Independent Think Tank & Educational Foundation
Incorporated in Delaware, we’re an established 501(c)3 foundation that’s turning research into education, education into reform, and reform into results.
We’re changing the conversation. Our Strategic Partners can:
Shape the next generation of market reform
Accelerate pro-growth policy and innovation
Support research that informs national legislation
Drive measurable change, not charity
Our Unique Approach
Research, Study & Analysis
We study the drivers of growth.
Conduct policy and economic research across key verticals.
Policy Proposals & Outreach
We translate insight into action.
Convert research into actionable policy recommendations through targeted briefings, roundtables, and direct engagement with decision-makers.
Engagement & Education
We educate and mobilize the public.
Simplify complex findings through media-friendly summaries, data visualizations, webinars, and newsletters to inform public dialogue.
Feedback & Improvement
We refine and measure our impact.
Gather input from policymakers, industry leaders, and academics - tracking legislative and regulatory outcomes to improve future work.
Meet David Weild
Our Founder & “The Father of the JOBS Act”
Our founder is the only living American to have catalyzed the passage of major pro-capital access legislation: David Weild. He is known as “The Father of the JOBS Act” for his lead authorship of the economic papers (plus his testimony) that led to the JOBS Act (The Act).
The Act sparked a surge in investment and innovation. Tripling the biotechnology IPO market and contributing to 18 new drug approvals in its first five years - and it funded Moderna’s mRNA technology that enabled the COVID vaccine credited with saving more than two million lives. It also expanded access to equity capital for low-income individuals by creating legal pathways, including Reg CF (Crowdfunding), Reg D 506(c) (generally solicited private placements), and Reg A+, allowing those without wealthy networks to raise money from strangers. Today, the Act is even included on FINRA licensing exams.
The JOBS Act (2012) — Passed into law on April 5, 2012, modernizing pathways for small companies to go public and raise capital.
JOBS Act 2.0 (“The FAST Act,” 2015) — Built upon the original JOBS Act to further streamline IPO processes and expand access for emerging companies.
JOBS Act 3.0 (2018) — Passed the House 406–4 with broad bipartisan support before stalling due to the government shutdown; remains a key legislative priority for revival.
SEC Enhancements (2020) — The SEC raised Regulation Crowdfunding limits from $1.07M → $5M and Regulation A+ limits from $50M → $75M, expanding opportunities for entrepreneurs nationwide.
